Skip to content

Opening book details…

About this Medicine article

The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization by Hokland, S. L.; Horsman, M. R. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Hokland, S. L.; Horsman, M. R.
Publisher
Informa plc; Informa UK (Taylor & Francis); Taylor & Francis; Informa UK Limited (ISSN 0265-6736)
Published
2007
Field
Medicine (Health Sciences)

More by Hokland, S. L.; Horsman, M. R.

Browse all works by Hokland, S. L.; Horsman, M. R.